Cargando…
KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy
ABSTRACT. -associated retinopathy or “cone dystrophy with supernormal rod responses” is an autosomal recessive cone-rod dystrophy with pathognomonic ERG findings. This gene encodes Kv8.2, a voltage-gated potassium channel subunit that acts as a modulator by shifting the activation range of the K(+)...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446039/ https://www.ncbi.nlm.nih.gov/pubmed/32441199 http://dx.doi.org/10.1080/13816810.2020.1766087 |
_version_ | 1783574098395267072 |
---|---|
author | Guimaraes, Thales A. C. De Georgiou, Michalis Robson, Anthony G. Michaelides, Michel |
author_facet | Guimaraes, Thales A. C. De Georgiou, Michalis Robson, Anthony G. Michaelides, Michel |
author_sort | Guimaraes, Thales A. C. De |
collection | PubMed |
description | ABSTRACT. -associated retinopathy or “cone dystrophy with supernormal rod responses” is an autosomal recessive cone-rod dystrophy with pathognomonic ERG findings. This gene encodes Kv8.2, a voltage-gated potassium channel subunit that acts as a modulator by shifting the activation range of the K(+) channels in photoreceptor inner segments. Currently, no treatment is available for the condition. However, there is a lack of prospective long-term data in large molecularly confirmed cohorts, which is a prerequisite for accurate patient counselling/prognostication, to identify an optimal window for intervention and outcome measures, and ultimately to design future therapy trials. Herein we provide a detailed review of the clinical features, retinal imaging, electrophysiology and psychophysical studies, molecular genetics, and briefly discuss future prospects for therapy trials. |
format | Online Article Text |
id | pubmed-7446039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-74460392020-09-14 KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy Guimaraes, Thales A. C. De Georgiou, Michalis Robson, Anthony G. Michaelides, Michel Ophthalmic Genet Reviews ABSTRACT. -associated retinopathy or “cone dystrophy with supernormal rod responses” is an autosomal recessive cone-rod dystrophy with pathognomonic ERG findings. This gene encodes Kv8.2, a voltage-gated potassium channel subunit that acts as a modulator by shifting the activation range of the K(+) channels in photoreceptor inner segments. Currently, no treatment is available for the condition. However, there is a lack of prospective long-term data in large molecularly confirmed cohorts, which is a prerequisite for accurate patient counselling/prognostication, to identify an optimal window for intervention and outcome measures, and ultimately to design future therapy trials. Herein we provide a detailed review of the clinical features, retinal imaging, electrophysiology and psychophysical studies, molecular genetics, and briefly discuss future prospects for therapy trials. Taylor & Francis 2020-05-22 /pmc/articles/PMC7446039/ /pubmed/32441199 http://dx.doi.org/10.1080/13816810.2020.1766087 Text en © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Guimaraes, Thales A. C. De Georgiou, Michalis Robson, Anthony G. Michaelides, Michel KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy |
title | KCNV2 retinopathy: clinical features, molecular
genetics and directions for future therapy |
title_full | KCNV2 retinopathy: clinical features, molecular
genetics and directions for future therapy |
title_fullStr | KCNV2 retinopathy: clinical features, molecular
genetics and directions for future therapy |
title_full_unstemmed | KCNV2 retinopathy: clinical features, molecular
genetics and directions for future therapy |
title_short | KCNV2 retinopathy: clinical features, molecular
genetics and directions for future therapy |
title_sort | kcnv2 retinopathy: clinical features, molecular
genetics and directions for future therapy |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446039/ https://www.ncbi.nlm.nih.gov/pubmed/32441199 http://dx.doi.org/10.1080/13816810.2020.1766087 |
work_keys_str_mv | AT guimaraesthalesacde kcnv2retinopathyclinicalfeaturesmoleculargeneticsanddirectionsforfuturetherapy AT georgioumichalis kcnv2retinopathyclinicalfeaturesmoleculargeneticsanddirectionsforfuturetherapy AT robsonanthonyg kcnv2retinopathyclinicalfeaturesmoleculargeneticsanddirectionsforfuturetherapy AT michaelidesmichel kcnv2retinopathyclinicalfeaturesmoleculargeneticsanddirectionsforfuturetherapy |